© 2026 Nanjing Finechem Holdings Co., Ltd,
All Right Reserved
Science often moves forward by inches, not leaps, and that’s clear in the history of 2-Methyl-5-nitroimidazole. This compound came out of a mid-20th century surge in interest toward heterocyclic molecules, when chemists realized that small tweaks to a molecule’s structure could lead to dramatic changes in what it could do. The rise of imidazole derivatives in medicine made researchers hunt for ways to add both methyl and nitro groups to the backbone, giving birth to 2-Methyl-5-nitroimidazole. At first, research just focused on finding new synthetic techniques and understanding its reactivity. The real turning point happened when it was recognized as a building block for antibiotics, especially nitroimidazole drugs that put up a fight against anaerobic bacteria and protozoa. Over the decades, every lab batch and notebook scribble about this compound showed how patient, often thankless tinkering still drives pharmaceutical breakthroughs.
To someone unfamiliar, 2-Methyl-5-nitroimidazole looks like a minor member of the vast imidazole family. In reality, its addition of both a methyl and a nitro group cranks up its importance. Rather than ending up as a lab curiosity, it became a critical intermediate and reference compound. Chemists prize it for stability and for the way it helps them explore structure-activity relationships in drug development. This molecule also found its way beyond synthetic chemistry benches, turning into a marker for metabolic studies and an object of curiosity in academic circles. Despite its niche spot, it stands out whenever the subject of antimicrobial resistance comes up, since it’s part of a class known for helping humanity claw back ground from stubborn infections.
This nitroimidazole offers more than the sum of its parts. On the practical side, it usually crystallizes in a way that resists moisture a bit better than some related compounds. That keeps the sample usable and less finicky during experiments or industrial use. Its melting point and solubility help guide synthetic choices — dissolving well in polar solvents, yet remaining robust enough to let handling in less controlled lab settings. The electron-withdrawing nitro group and small methyl branch tweak how it interacts with other molecules, a feature that steers its activity and keeps it in the running when drug candidates are screened. Simple but very real properties like odor, color, and behavior in common solvents remind us that chemistry still comes down to how something actually behaves in your hands.
Rules shape lab work, so clarity on labeling and purity cannot be skipped over. For 2-Methyl-5-nitroimidazole, reputable suppliers support research by giving precise purity levels, usually as a percent range. Labels carry standard identifiers and structural diagrams, making cross-referencing a smooth process and preventing confusion with other nitroimidazoles that differ by just one group. Those conventions—from lot numbers to storage instructions—reduce the chance of error, a small but critical defense against wasted effort and failed syntheses. Over time, careful documentation led to a culture where chemists expect and demand transparency about every bottle and batch, not just what ends up in the final product.
Crafting this molecule didn’t start off as an obvious process. Early chemists explored substituting on imidazole rings under acidic or basic conditions, but found side reactions cropping up when either the nitro or methyl group went in first. Gradually, stepwise syntheses—the order in which to tack on methyl or nitro—became less a matter of theory and more an art refined through trial, error, and well-documented lab disasters. Today, one route starts from methylimidazole, then carefully introduces the nitro group. Another path switches the order, always tweaking temperature, solvents, and reaction times. Each approach carries trade-offs, but both reflect a chemistry tradition of sticking with what's proven to work under real-world conditions rather than theoretical perfection.
Tinkering with 2-Methyl-5-nitroimidazole marks a rite of passage for synthetic chemists. The nitro group offers a handle for reduction to an amine, which then opens doors for other modifications. The methyl site holds up against casual attack, but with the right catalyst or electrophile, can invite more complex chemistry. Transformations here enabled the rise of dozens of nitroimidazole-based drugs. Laboratory curiosity doesn’t just stop with textbook modifications; reactivity studies offer a path to more exotic heterocycles and cross-coupling partners. Through these reactions, the substance shifted from a medical agent to a flexible building block for both academia and industry. Its place in library synthesis sometimes gets overlooked, but for anyone who’s spent hours optimizing a reaction, that dependability counts for a lot more than flashy novelty.
Names matter in chemistry, not just for paperwork, but to keep order in a universe teeming with similar-looking substances. Across literature, 2-Methyl-5-nitroimidazole goes by several names, reflecting different naming conventions and languages. Older texts sometimes call it 1-methyl-2-nitroimidazole—an artifact of shifting numbering systems. Other synonyms pile up, mostly to distinguish it from compounds with the nitro or methyl elsewhere on the ring. In pharmaceutical registers, trade names emerge wherever the compound serves as a precursor or an intermediate to something sold in pharmacies. This web of synonyms sometimes confuses newcomers, but seasoned chemists rely on context, structure diagrams, and memory to cut through the tangle and avoid costly mistakes.
Careful preparation and handling remain non-negotiable. The nitro group, while stable during routine work, means that caution comes before convenience. Safety data sheets cover everything from accidental spills to chronic exposure risks. Standard operating procedures became stitched into the culture of any lab or plant handling nitroimidazoles, informed by decades of near-misses and a few real incidents where inhalation or skin contact led to unwanted side effects. The practical lesson here echoes across research and industry: assumptions make for poor safety policy. Direct experience and strict adherence to tested routines get better results than shortcuts or unverified tips. Personal protective equipment, fume hoods, and regular safety drills turn what might seem like cautious overkill into just plain common sense.
Few compounds walk as many paths as this one. Beyond its direct use in chemical synthesis, 2-Methyl-5-nitroimidazole stands out as a raw material in the search for new antibiotics. Medicinal chemists mine it for the parent structure in anti-parasitic and anti-anaerobic drugs. Environmental labs sometimes turn to derivatives for nitro reduction studies, learning how pollutants break down in soil and water. Analytical chemists take advantage of its stable character to trace metabolic changes, reinforcing its value in lab method development. All these fields push the molecule in directions its original discoverers never anticipated, showing how openness to surprise often outpaces grand plans.
Living through ongoing research brings a feeling of excitement and challenge. Every year, published papers report new derivatives, test new biological pathways, or map out yet another reaction that transforms the parent molecule. The cycle of discovery goes on, each lab adding a footnote to a story spanning decades. This compound often slips into a supporting role, outshone by flashier breakthroughs, but its reliability as a scaffold means more research papers and patents keep building on its foundation. Real advances come from hard-won insights—unexpected side products, reaction upsets that led to new families of drugs, and the steady drive from iterative optimization. That makes the difference between mere investigation and true innovation.
Every chemical brings risk, and understanding toxicity means much more than just ticking through regulatory boxes. Researchers spent years unraveling how 2-Methyl-5-nitroimidazole interacts with human and animal tissue. Like many nitro-containing compounds, its ability to spawn reactive intermediates during metabolism can pose dangers at certain exposure levels. In developing new drugs, teams rigorously test breakdown products, seeking patterns that predict side effects or toxic responses. Theoretical models help, but the real world throws in variables—enzymes, co-factors, uncontrolled human metabolism—that demand direct study. Success comes from respecting the line between therapeutic and hazardous, a lesson handed down in every toxicology briefing and review article.
Looking down the road, 2-Methyl-5-nitroimidazole holds promise beyond its established uses. Antimicrobial resistance keeps finding new ways to threaten public health, and nitroimidazole derivatives may form the basis for future drug classes with fresh mechanisms of action. Beyond pharmaceuticals, the compound could help support green chemistry goals, serving as a model for selective catalysis or for cleanup strategies in polluted environments. The relentless pace of innovation means untapped applications still hide in academic journals or untested reaction vessels. Bringing those ideas into practical use means mixing hard science, creative thinking, and above all, a willingness to take the long way round until something truly new emerges. Progress hinges on the same persistence and curiosity that brought this compound to its current place on the scientific map.
2-Methyl-5-nitroimidazole belongs to a group of chemicals known for their strong antibacterial and antiprotozoal powers. This compound serves as a critical ingredient in the pharmaceutical world, especially in the formulation of drugs targeting infections from bacteria and certain parasites. You’ll mostly find it featured in synthesis processes that lead to medicines treating infections in both the digestive system and vaginal area. Its chemical cousins, such as metronidazole, have been favored by doctors for a long time, and 2-Methyl-5-nitroimidazole often enters the spotlight during research for new or improved treatments.
Bacterial and parasitic infections don’t just slow people down for a few days. For patients in resource-limited areas, such diseases often turn life-threatening. My grandfather’s rural clinic struggled with recurrent outbreaks of bacterial infections. Without access to advanced drugs, communities simply hope for the best. 2-Methyl-5-nitroimidazole gives hope in these cases, enabling researchers and doctors to hunt for drugs that work faster and stand up to resistant strains of bacteria.
Clinical research points to a growing need for new drugs. Antibiotic resistance keeps spreading. When certain bacteria stop responding to old faithfuls like penicillin, options can run thin. Studies published in journals such as Antimicrobial Agents and Chemotherapy highlight how nitroimidazole derivatives, including the one we’re discussing, keep popping up as strong candidates for fighting stubborn infections. Many drug developers see these chemicals as stepping stones for creating next-generation treatments.
With powerful chemicals always come worries. Sometimes these compounds, if not handled with proper oversight, slip into black-market medicines or get used in ways doctors wouldn’t recommend. Poor regulation risks exposing people to counterfeit or unsafe drugs. 2-Methyl-5-nitroimidazole, when processed without quality controls, can turn toxic or lose its infection-fighting punch. Every batch needs careful monitoring, strict documentation, and transparent supply chains. Health authorities need to keep up with changing manufacturing methods and test for impurities at every stage.
One workable direction comes from government cooperation with international watchdogs, clamping down on shady suppliers and promoting fair access to quality medicines. Public education also makes a difference—regular folks need fast, clear information about safe medications. Medical supply chains work better when all players—researchers, regulators, and pharmacy owners—get regular checks and training. In my experience covering rural health campaigns, transparency and practical teaching helped clinics avoid fakes and save lives. Constant updates to guidelines push everyone forward, ensuring treatments crafted from 2-Methyl-5-nitroimidazole actually deliver relief and not new headaches.
New drug development does not move at lightning speed, but with a stubborn problem like antimicrobial resistance, compounds like 2-Methyl-5-nitroimidazole help keep science in the race. By demanding quality from every lab and every shipment, and giving local doctors the tools to track their supplies, we give these essential compounds a shot at making a real difference for people who need them most.
2-Methyl-5-nitroimidazole plays an important role in research and synthesis, especially in pharmaceuticals and agriculture. Like many nitro compounds, it needs careful handling to keep people and property safe. Over years working in labs, one lesson stands out: safe storage isn’t just about following rules, it’s about protecting the people and discoveries that make science move forward.
Storing this compound below room temperature slows down unwanted reactions and preserves its quality. It usually does best in a cool, dry place. Heat often speeds up chemical changes. Even just a warm storage room or direct sunlight can stress sensitive substances, especially those with a nitro group like this one. Researchers at the University of Milan showed degradation happens faster as temperatures rise, turning routine storage into a risk for experiments and people alike.
Bright lights break down certain chemicals faster. Fluorescent bulbs, afternoon sunbeams—those speed up breakdown, sometimes releasing toxic fumes. Keeping 2-Methyl-5-nitroimidazole in amber bottles in dark cabinets helps block out these dangers. Years of lab experience confirm this tiny step cuts down on ruined batches and safety incidents.
Humidity often slips under the radar. Water sneaks in and speeds up decompositions or, worse, triggers reactive incidents with nitro compounds. Sealing 2-Methyl-5-nitroimidazole in an airtight container keeps moisture away. Desiccators lined with silica gel protect it further. Even the smallest leak in a bag or bottle leads to wasted product and unrepeatable results in the lab. Safety data sheets from Sigma-Aldrich recommend this level of dryness. I remember a summer internship where ignoring this advice meant cleaning up sticky, yellowed goo that had leaked. That mistake made me a believer in dry storage.
The risks go beyond ruined chemicals. 2-Methyl-5-nitroimidazole can be toxic by inhalation, skin, or even accidental ingestion. Spilled powder in a damp or poorly ventilated spot risks exposure. Keeping it in a secure container reduces those chances. Well-ventilated storage spaces matter, too. Bad reactions and accidents multiply when air stands still. I’ve seen too many people underestimate a “dusty corner” of a storeroom, only to deal with a bigger headache days later. A chemical fume hood isn’t a luxury—sometimes, it is the only thing between a safe shift and a reportable accident.
Regulatory bodies like OSHA and the European Chemicals Agency require that even small labs follow these protection standards. Violation fines pile up quickly, but the bigger cost is always trust and reputation in the scientific and medical communities. Insurers want proof of proper storage. Documentation—dating, labeling, keeping inventory—turns chaotic supply closets into easy-to-navigate shelves. It saves money in the long run, too: no more last-minute reorders or mysterious stockouts when everyone can see and understand what’s on the shelf.
Years spent around these substances taught me that safe, dry, cool, and secure conditions for 2-Methyl-5-nitroimidazole can save time, money, and sometimes even lives. No one regrets a few extra minutes spent on careful storage—but many regret a moment’s negligence.
Plenty of chemicals from labs or industrial settings never make headlines. 2-Methyl-5-nitroimidazole isn’t a household name, but scientists and anyone who works near chemical stocks know it for its curious nature. Structurally, it fits into a wider family that includes several drugs and antimicrobial substances. Sometimes, sharing a chemical family tips us off to toxic or hazardous tendencies.
Every safety data sheet I’ve read for this molecule flags its risks. It irritates skin and eyes on contact. Breathe in the dust or fumes, and it irritates nasal passages or even the lungs. The molecule’s nitro group raises eyebrows — those groups sometimes show up in chemicals that mess with DNA in animal tests. Safety organizations like ECHA and GHS point out the risk of acute and chronic health effects: 2-Methyl-5-nitroimidazole lands on hazardous chemical lists. This isn’t just paperwork; it means safe handling rules exist for a reason.
Anyone in research learns to take small-molecule toxicity seriously. Workers preparing, transporting, or disposing of chemicals with a nitroimidazole structure have heard the warnings. Gloves and eye protection come out by habit. In my university days, a spilled drop on the sleeve meant a visit to the eyewash even before reading labels. Waiting to learn the hard way never pays off. Beyond the direct contact, disposal presents another risk. Local water and soil don’t need new pollutants. Nitroimidazoles can persist, and some degrade slowly, so labs collect waste for specialist disposal.
Animal testing shapes most of the published data. Repeated exposure at moderate levels damages organs and blood chemistry in lab animals. Long-term effects remain under study — not every nitroimidazole compound gets classified as cancer-causing, but authorities demand caution. Mutagenicity shows up in some tests, which tends to lead regulators to err on the safe side. No one’s running clinical trials in people for a chemical like this when safer options exist for similar uses.
Nothing about 2-Methyl-5-nitroimidazole encourages taking shortcuts. If a chemical’s safety data points to toxicity, people near it plan ahead: controlled ventilation, protective gloves, goggles, and proper lab coats come standard. I’ve seen shops color-code the storage shelves and post reminders to avoid accidental mixing — safety culture shows up in every clear label and documented procedure. For clean-up, absorbent pads and waste buckets keep contamination from spreading. Workers check that chemical waste heads to the right bins instead of the regular trash. These habits come not just from rules, but from experience — too many stories of burns, rashes, and lessons learned.
Companies and researchers keep searching for alternatives that lower risks to health and the environment. If a process calls for a hazardous nitroimidazole, only real necessity justifies using it, and engineers seek substitutes whenever possible. Regulations help, but personal responsibility goes further. Everyone who handles 2-Methyl-5-nitroimidazole — or any chemical flagged as hazardous — owes it to colleagues, communities, and the planet to treat risk as more than a technicality.
2-Methyl-5-nitroimidazole doesn’t always grab attention until someone brings up metronidazole, one of the best-known antibiotics that relies on the same core structure. This isn’t just chemistry drawn on a notepad; these molecules help drive clinical decisions in hospitals and local pharmacies alike. The backbone of 2-Methyl-5-nitroimidazole shapes how it acts in biological settings and impacts public health outcomes through its use in anti-infective drugs.
Picture a five-membered ring, looking nothing like the typical hexagons seen in high school texts about benzene. This ring stands out due to the presence of two nitrogen atoms at the 1 and 3 positions. Chemically, the structure unfolds like this: a methyl group tacked onto the second carbon, and a nitro group stuck on the fifth spot. In chemistry shorthand, this gets written as C4H5N3O2. The actual molecule twists and bends in three dimensions, packing its electron clouds and side groups tightly together, which affects how easily it slips through membranes or binds to proteins inside cells.
This isn’t just another molecular model. Life-saving antibiotics like metronidazole have built their reputation on this scaffold. Doctors rely on its shape and functional groups to interrupt the DNA of infectious parasites and certain bacteria, clearing up life-threatening infections like bacterial vaginosis, trichomoniasis, and some forms of dysentery. Because the nitro group lies at the fifth position, it triggers the right kind of reaction, only in low-oxygen environments found in specific pathogens. That’s a practical twist of nature and chemistry, limiting side effects compared to older, less selective drugs.
Making pure 2-Methyl-5-nitroimidazole isn’t always simple. Synthetic chemists must carefully balance every step, since tiny mistakes in positioning or contamination can lead to ineffective drugs or increased toxicity. Working in industry, it always impressed me how often lab teams stopped to check purity or correct byproducts before scaling up production. Medicinal chemistry doesn’t offer many shortcuts; chasing yields or skipping analytical checks erodes both efficacy and trust.
Now more than ever, resistance threatens the value of this entire family of medications. Long courses of treatment and easy over-the-counter access put real pressure on the effectiveness of 2-methyl-5-nitroimidazole-based drugs. Data from the CDC and WHO track steady increases in resistance among anaerobic bacteria, especially in regions where antibiotics see frequent, unsupervised use. Health professionals and patients alike must approach prescribing decisions with a clear understanding of the underlying chemistry and its impact on microbial survival.
New research focuses on tweaking the imidazole core, developing analogs with better selectivity or lower risk of toxic side effects. Collaborative projects often bring in virologists, pharmacologists, and even computer scientists, all aiming to model drug-binding or resistance pathways. Well-supported research consistently comes back to a central lesson: minor changes at the molecular level can make a world of difference in drug safety and success rates.
Good chemistry alone doesn’t guarantee results. Robust regulation pushes manufacturers to maintain strict quality controls, while strong evidence-based guidelines help clinics fight back against drug resistance. Public awareness should grow alongside technical innovation, so the next breakthroughs benefit more people, for longer spans of time.
2-Methyl-5-nitroimidazole sits in that category of chemicals with a big name and a fair share of risk. You’ll find it in some pharmaceutical manufacturing labs, research centers, and maybe even in some corners of analytical chemistry. Its chemical cousins include other nitroimidazoles, a group known for medical uses—think antibiotics. But the “nitro” part signals a red flag. Chemicals like this can be toxic to humans and to the environment, and ignoring those risks means asking for trouble.
Chemical safety isn’t just about what happens in the lab; it’s about everyone who might eventually pick up the pieces, from janitors to garbage sorters to aquatic life if it seeps into water. 2-Methyl-5-nitroimidazole can irritate the skin, eyes, and lungs. There’s even evidence that nitroimidazoles can harm liver function with enough exposure. These aren’t just theoretical risks. Spills, splashes, and poor ventilation have real consequences, especially for students or staff new to handling chemicals.
Training goes hand-in-hand with equipment. Anyone handling this stuff needs gloves, lab coats, protective eyewear, and a fume hood. Labels matter. Every bottle should make it obvious what you’re working with. Complacency turns small mistakes into big accidents.
You don’t just leave reactive chemicals out in the open or tuck them away with bleach and acids. Separate storage, away from heat, light, and incompatible materials, stays key. Talking to an experienced chemical safety officer or referencing a reliable material safety data sheet (MSDS) always helps.
Tossing 2-Methyl-5-nitroimidazole in the trash or down the drain opens the door to pollution and future health risks. City wastewater plants aren’t built to handle compounds like this; they end up downstream, possibly in rivers or water tables. That’s serious, especially since nitro compounds can hurt aquatic ecosystems and even end up in drinking water.
The right way means collecting the waste in a clearly marked, sealed container. Local hazardous waste contractors or institutional hazardous waste programs know the drill—they’ll take care of it through incineration or another approved method. Never skip paperwork. The trail matters if someone down the line needs answers about what’s in their waste stream.
In some labs, safe disposal feels like an afterthought, shoved in the back of dusty training manuals. But simple changes make a difference. More frequent safety refreshers, accessible resources on handling specific chemicals, and making disposal bins more visible in labs lower the chance of mistakes.
Manufacturers and suppliers can step up too. Clear guidance on disposal, plus easy-to-read hazard warnings, help both seasoned chemists and new students. If the big words on the label don’t make sense, they won’t help stop an accident. Quick reference guides or QR codes linking to safe handling videos would make a real-world difference.
Anyone who’s worked in a busy lab knows the job’s tough enough without guessing about safety. Taking care with chemicals like 2-Methyl-5-nitroimidazole avoids headaches later—both for people and for the planet.
| Names | |
| Preferred IUPAC name | 2-Methyl-5-nitro-1H-imidazole |
| Other names |
Dimetridazole 2-Methyl-5-nitro-1H-imidazole |
| Pronunciation | /tuː ˈmɛθ.ɪl faɪv ˈnaɪ.trə.ɪˈmɪd.əˌzoʊl/ |
| Identifiers | |
| CAS Number | 693-17-8 |
| Beilstein Reference | 100367 |
| ChEBI | CHEBI:44060 |
| ChEMBL | CHEMBL1435 |
| ChemSpider | 15807 |
| DrugBank | DB00916 |
| ECHA InfoCard | 29b8b306-73d5-4d86-9675-ffaae9296911 |
| EC Number | 213-234-5 |
| Gmelin Reference | 79243 |
| KEGG | C06580 |
| MeSH | D008876 |
| PubChem CID | 14334 |
| RTECS number | MU8220000 |
| UNII | 529D5X1E4A |
| UN number | UN2811 |
| Properties | |
| Chemical formula | C4H5N3O2 |
| Molar mass | 129.11 g/mol |
| Appearance | Light yellow to yellow crystalline powder |
| Odor | Odorless |
| Density | 1.36 g/cm³ |
| Solubility in water | Slightly soluble |
| log P | 0.02 |
| Vapor pressure | 1.76E-5 mmHg at 25°C |
| Acidity (pKa) | 13.8 |
| Basicity (pKb) | 9.70 |
| Magnetic susceptibility (χ) | -35.9×10⁻⁶ cm³/mol |
| Refractive index (nD) | 1.570 |
| Viscosity | 1.37 cP (25°C) |
| Dipole moment | 4.29 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 160.7 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | -24.2 kJ/mol |
| Std enthalpy of combustion (ΔcH⦵298) | -3524 kJ/mol |
| Pharmacology | |
| ATC code | J01XD03 |
| Hazards | |
| GHS labelling | GHS02,GHS07 |
| Pictograms | GHS07 |
| Signal word | Warning |
| Hazard statements | H302, H315, H319, H335 |
| Precautionary statements | P264, P270, P273, P301+P312, P305+P351+P338, P330, P501 |
| NFPA 704 (fire diamond) | 1-3-0 |
| Flash point | > 164°C |
| Autoignition temperature | 380 °C |
| Lethal dose or concentration | LD50 oral rat 1300 mg/kg |
| LD50 (median dose) | LD50 (median dose): 850 mg/kg (oral, rat) |
| NIOSH | Not established |
| PEL (Permissible) | PEL (Permissible Exposure Limit) for 2-Methyl-5-nitroimidazole: Not established |
| REL (Recommended) | REL (Recommended Exposure Limit) for 2-Methyl-5-nitroimidazole: "No REL established |
| Related compounds | |
| Related compounds |
Metronidazole Dimetridazole Ornidazole Tinidazole Secnidazole |
